Sunday, September 18, 2022

Ultragenyx Pharmaceutical - RARE Stock Forecast, Price & News - MarketBeat

The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of ...
https://www.google.com/url?rct=j&sa=t&url=https://www.marketbeat.com/stocks/NASDAQ/RARE/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw1mcFh1gKk-GqP2Fx_Flj2o
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...